Press Releases

As an institution of application-oriented research, the Fraunhofer IBMT attaches great importance to the information it provides journalists, customers and the public at large.

Current Topics

 

19.6.2024

Intelligent and flexible ultrasonic sensor system based on the modular principle

Fraunhofer ZSI: Project »SonoOne«

 

3.6.2024

Brain stimulation with 3D Ultrasound to treat neurological diseases and conditions

Medical engineering

 

2.5.2024

Bioreactor research processes and cryotechnologies improve active ingredient tests using human cell cultures

Drug discovery for new therapies: R2U-Tox Assay - Ready-to-use-Toxicity Assay

 

17.4.2024

Fraunhofer IBMT signs MoUs with KCL and KIST Europe

Joint research on nanosafety assessment technologies for global regulatory measures, development of new alternative in vitro testing methods, biobanking and cryopreservation.

 

18.3.2024

"CombiDiag": Network of young scientists for research into a combinatorial diagnostics of Alzheimer’s disease

Fraunhofer IBMT Partner in the EU-Project "CombiDiag"

 

12.1.2024

Development of a miniaturized lung and kidney support device for critically ill newborns

Fraunhofer IBMT Partner in the EU Project "ArtPlac"

 

4.10.2023

Bidirectional control of prosthetic hands using ultrasonic sensors

Fraunhofer IBMT in the EU-Project SOMA - Neuroprostetics

 

10.7.2023

Development and validation of a software platform for the prevention, detection and analysis of cyberattacks in the healthcare sector

Fraunhofer IBMT Partner in the EU Project "AI4HealthSec"

 

2.5.2023

Human-machine interface stops muscle tremors

Neuromedicine - Fraunhofer Institute for Biomedical Engineering IBMT Partner in the  EU Joint Project EXTEND

 

27.2.2023

A new EBiSC iPSC-derived neuronal cell product simplifies neuroscience research

The European Bank for induced Pluripotent Stem Cells (EBiSC) is happy to announce a new iPSC derived neuronal cell product - EBiSC-NEUR1 which can be used directly from thaw for downstream applications.

 

2.2.2023

A new generation of microimplants

A new generation of interactive microimplants developed by the innovation cluster INTAKT, which is funded by the German Federal Ministry of Education and Research (BMBF) and coordinated by the Fraunhofer Institute for Biomedical Engineering IBMT helps as miniature assistants to stimulate in cases of tinnitus or digestive tract disorders or helps a person’s hand to regain the ability to grip.


 

 

 

2.11.2022

Fraunhofer at MEDICA/COMPAMED 2022

BioSensoLab - Biological laboratory to go

Researchers from the Fraunhofer Institute for Biomedical Engineering IBMT have developed the “BioSensoLab“, a mobile biological laboratory with which they can demonstrate new developments to customers and test them together – on site at their companies.

 

13.9.2022

Fraunhofer IBMT in EC-Horizon 2020 - FET Open Project GLADIATOR

New technologies for cancer monitoring and therapy
A transdisciplinary, paradigm-shifting, approach with bio-nanodevice interfaces

 

12.7.2022

Fraunhofer IBMT is part of the European Partnership for the Assessment of Risks from Chemicals (PARC)

Next-generation chemical risk assessment


 

 

 

6.7.2022

Fraunhofer IBMT Partner in the new EU Project “SafePolyMed”

Safer Drug Treatment and Enhanced Patient Empowerment


 

 

 

8.6.2022

Human cell-based test systems for toxicity studies

R2U-Tox-Assay - Ready-to-use Toxicity Screening Assay based on iPS-Technologies

 

 

17.5.2022

EBiSC2 and FAIRplus are improving FAIRness of stem cell data

The FAIRplus and EBiSC2 projects are joining forces to improve how ‘FAIR’ standards (Findability, Accessibility, Interoperability and Reusability) can be applied to human induced Pluripotent Stem Cell (iPSC) line data.


 

 

 

23.2.2022

New Fraunhofer Center for Sensor Intelligence in Saarland

On February 23, 2022, Saarland's Minister President Tobias Hans and the President of the Fraunhofer-Gesellschaft, Prof. Reimund Neugebauer, signed an agreement to establish the Fraunhofer Center for Sensor Intelligence as a joint project between the Fraunhofer IBMT and the Fraunhofer IZFP.


 

 

 

3.11.2021

Safe, patient-friendly implants for personalized therapy

The Fraunhofer IBMT presents its miniaturized and networked active implants at COMPAMED/MEDICA 2021 from November 15-18, 2021 in Düsseldorf, Germany (Hall 13, Stand D60).

 

 

 

 

3.11.2021

Stem cells from the bioreactor

The Fraunhofer SPT (IBMT and ISC) presents its biotechnological processes at MEDICA 2021 from November 15-18, 22021 in Düsseldorf, Germany(Hall 3, Stand E74).


 

 

 

11.8.2021

Video on MobiLabV2 in the use in testing on SARS-CoV-2

MobiLabV2 in testing on SARS-CoV-2 infections